Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms

Climacteric

Volumn 11, Issue 2, 2008, Pages 135-143

  Pettersen, P C ^a   Raundahl, J ^b   Loog, M ^d   Nielsen, M ^b,d   Tanko L B ^c   Christiansen, C ^d  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Spree Pharma A/S   (Denmark)

^d NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

Breast Density; Computer based Methods; Nasal and Oral HRT; Postmenopausal Women; Safety

Indexed keywords

CALCIUM; ESTRADIOL; PLACEBO; PROGESTERONE; TRIMEGESTONE; VITAMIN D;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POST HOC ANALYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AGED; BREAST; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; PROGESTINS; PROMEGESTONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 41349096701     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130801930385     Document Type: Article

References (30)

1. Davidson MH, Maki KC, Marx P, et al. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med 2000;160:3315-25
2. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
3. Nielsen TF, Ravn P, Bagger YZ, Warming L, Christiansen C. Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int 2004;15:168-74
4. Devissaguet JP, Brion N, Lhote O, Deloffre P. Pulsed estrogen therapy: pharmacokinetics of 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet 1999;24:265-71
5. Scott RT Jr, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: a crossover study using gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991;77:758-64
6. Studd J, Pornel B, Marton I, et al. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomized dose-response study. Aerodiol Study Group. Lancet 1999;353:1574-8
7. YesildaglarN, Erkaya S, Uygur D, Gol K, Bingol B, Gunenc Z. Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause. Hum Reprod 2004;19:210-13
8. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-7
9. Laya MB, Larson EB, Taplin SH,White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88:643-9
10. Titus-Ernstoff L, Tosteson ANA, Kasales C, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006;17:1281-90
11. Gapstur SM, López P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE. Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomark Prev 2003;12:1074-80
12. American College of Radiology (ACR). Breast Imaging Reporting and Data System Atlas (BIRADS® Atlas). Reston, VA: American College of Radiology, 2003
13. Warming L, Ravn P, Spielman D, Delmas P, Christiansen C. Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause 2004;11:337-42
14. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analyses of mammographic densities. Phys Med Biol 1994;39:1629-38
15. Raundahl J, Loog M, Nielsen M. Understanding Hessian-based density scoring. Proceedings of The 8th International Workshop on Digital Mammography, June, 2006
16. Raundahl J, Loog M, Nielsen M. Mammographic density measured as changes in tissue structure caused by HRT. In Reinhardt JM, Pluim JPW, eds. Medical Imaging 2006: Image Processing. Proceedings of the SPIE, Vol 6144, 2006:141-8
17. Raundahl J, Pettersen P, Loog M, Tankó LB, Nielsen M. Automated effect-specific breast density measures. IEEE Trans Med Image 2008;in press
18. Bremnes Y, Ursin G, Bjurstam N, Lund E, Gram IT. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Int J Cancer 2007;120:880-4
19. Topal NB, Ayhan S, Topal U, Bilgin T. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins. J Obstet Gynaecol Res 2006;32:305-8
20. Pongsatha S, Muttarak M, Chaovisitseree S, Luewan S, Panpanit A. Mammographic changes related to different types of hormonal therapies. J Med Assoc Thai 2006;89:123-9
21. Marchesoni D, Driul L, Ianni A, et al. Postmenopausal hormone therapy and mammographic breast density. Maturitas 2006;53:59-64
22. Conner P, Svane G, Azavedo E, et al. Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy. Fertil Steril 2004;81:1617-23
23. Sendag F, Cosan Terek M, Ozsener S, et al. Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 2001;76:445-50
24. Lundstrom E, Wilczec B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999;181:348-52
25. Crandall CJ, Karlamangla A, Huang MH, Ursin G, Guan M, Greendale GA. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. Arch Intern Med 2006;166:1578-84
26. Harma M, Oztürk A, Harma M. The effect of intranasal 17 beta-estradiol on mammographic breast density. Maturitas 2005;16:165-6
27. Mattsson LA, Christiansen C, Colau JC, et al. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 2000;182:545-52
28. Bulbul NH, Ozdens S, Dayicioglu V. Effects of hormone replacement therapy on mammographic findings. Arch Gynecol Obstet 2003;268:5-8
29. Genazzani AR, Bernardi F. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy. Climacteric 2002;5(Suppl 2):50-6
30. Kenemans P, Genazzani AR, Palacios S, Schneider HPG. Pulsed estrogen exposure selectively modulates tissue response: a hypothesis. Gynecol Endocrinol 2004;18:159-64